LINC01363: A protein with potential as a drug target or biomarker

Target Name: LINC01363

NCBI ID: G101928484

LINC01363

Other Name(s): RBSG4 | long intergenic non-protein coding RNA 1363 | Long intergenic non-protein coding RNA 1363

LINC01363: A protein with potential as a drug target or biomarker

LINC01363 (RBSG4) is a protein that is expressed in various tissues of the human body, including the brain, heart, kidneys, and liver. It is a member of the superfamily of RNA-binding proteins, known as RBPIs (ribonucleoprotein binding proteins), and is characterized by its ability to interact with specific RNA molecules.

One of the unique features of LINC01363 is its ability to form a stable complex with the protein p16INK4a, which is a key regulator of the cell cycle and has been implicated in various diseases, including cancer. This interaction between LINC01363 and p16INK4a has been shown to play a role in the regulation of cell growth, apoptosis (programmed cell death), and inflammation.

In addition to its interaction with p16INK4a, LINC01363 has also been shown to play a role in the regulation of other cellular processes, including cell adhesion, migration, and the development of tissues. For example, LINC01363 has been shown to be involved in the regulation of neuronal migration in the brain and has been implicated in the development of neurodegenerative diseases.

Despite its potential role in many important cellular processes, LINC01363 is not yet a well-studied protein, and there is limited information about its potential drug targets or biomarkers. However, its interaction with p16INK4a and its involvement in various cellular processes make it an attractive candidate for further research and potential development as a drug or biomarker.

In conclusion, LINC01363 is a protein that has the potential to be a drug target or biomarker due to its interaction with p16INK4a and its involvement in various cellular processes. Further research is needed to fully understand its role in the regulation of cellular processes and its potential as a drug or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1363

The "LINC01363 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01363 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets